News & Updates

Extended clopidogrel monotherapy after DAPT reduces bleeding events in ‘bi-risk’ ACS patients

16 Sep 2023 by

Extended clopidogrel monotherapy after a 9- to 12-month course of dual antiplatelet therapy (DAPT) reduces bleeding and ischaemic events in patients with acute coronary syndrome (ACS) who are at high risk for both events, according to the OPT-BIRISK* trial presented at ESC 2023.

Extended clopidogrel monotherapy after DAPT reduces bleeding events in ‘bi-risk’ ACS patients

16 Sep 2023

Food additives up risk of CVD

15 Sep 2023 by

Intake of additive emulsifiers, which is widely used in industrial foods, appears to increase the risk of cardiovascular disease (CVD), suggests a recent study.

Food additives up risk of CVD

15 Sep 2023

Comprehensive geriatric assessment reduces complications, mortality in vascular patients

15 Sep 2023 by

Vascular-Geriatric Service (VGS), the first formal Geriatric Liaison Service for surgical patients in a tertiary hospital in Singapore, has resulted in a significant decrease in medical complications and 30-day mortality in older frail patients with multimorbidity, reports a study.

Comprehensive geriatric assessment reduces complications, mortality in vascular patients

15 Sep 2023

Meditation beneficial for CAD patients

14 Sep 2023 by

In patients with coronary artery disease (CAD), augmenting their cardiac rehabilitation regimen with meditation may lead to improved quality of life (QoL), a study has shown.

Meditation beneficial for CAD patients

14 Sep 2023

Treating iron deficiency in heart failure provides some benefits

14 Sep 2023

Use of ferric carboxymaltose in patients who have heart failure with a reduced ejection fraction and iron deficiency appears to yield only numerical improvements the hierarchical composite of death, hospitalizations for heart failure, or 6-minute walk distance as compared with placebo, according to data from the HEART-FID trial.

Treating iron deficiency in heart failure provides some benefits

14 Sep 2023

Is it safe to take olmesartan in combination therapy for advanced hypertension?

14 Sep 2023 by

Use of olmesartan in combination practice is safe and results in similar cardiovascular composite outcomes, including myocardial infarction (MI), when compared with active comparators in hypertensive patients who need more than two antihypertensive medications, reports a study.

Is it safe to take olmesartan in combination therapy for advanced hypertension?

14 Sep 2023

Product Highlight - Nustendi

14 Sep 2023

Bempedoic acid 180 mg, ezetimibe 10 mg film-coated tablet

Product Highlight - Nustendi

14 Sep 2023

Product Highlight - Nilemdo

14 Sep 2023

Bempedoic acid film-coated tablet 180 mg

Product Highlight - Nilemdo

14 Sep 2023

Atrial fibrillation may accelerate cognitive decline in women

13 Sep 2023 by

Atrial fibrillation (AF) appears to contribute to an increased risk of rapid progresssion to mild cognitive impairment (MCI) and dementia in women, as reported in a study.

Atrial fibrillation may accelerate cognitive decline in women

13 Sep 2023

When is the best time to take antihypertensives?

13 Sep 2023

It remains uncertain whether morning or bedtime dosing of antihypertensive drugs is better than the other in terms of efficacy, but the latter appears to significantly reduce the incidence of myocardial infarction (MI), suggests a study.

When is the best time to take antihypertensives?

13 Sep 2023

News & Updates

Filter by Specialty:

Specialty:

Extended clopidogrel monotherapy after DAPT reduces bleeding events in ‘bi-risk’ ACS patients

Extended clopidogrel monotherapy after DAPT reduces bleeding events in ‘bi-risk’ ACS patients

Food additives up risk of CVD

Food additives up risk of CVD

Comprehensive geriatric assessment reduces complications, mortality in vascular patients

Comprehensive geriatric assessment reduces complications, mortality in vascular patients

Meditation beneficial for CAD patients

Meditation beneficial for CAD patients

Treating iron deficiency in heart failure provides some benefits

Treating iron deficiency in heart failure provides some benefits

Is it safe to take olmesartan in combination therapy for advanced hypertension?

Is it safe to take olmesartan in combination therapy for advanced hypertension?

Product Highlight - Nustendi

Product Highlight - Nustendi

Product Highlight - Nilemdo

Product Highlight - Nilemdo

Atrial fibrillation may accelerate cognitive decline in women

Atrial fibrillation may accelerate cognitive decline in women

When is the best time to take antihypertensives?

When is the best time to take antihypertensives?